Single-Photon Emission Computed Tomography (SPECT) Market Size to Grow by $ 620.21 mn through 2020-2024
The single-photon emission computed tomography (spect) market is expected to grow by $ 620.21 mn, accelerating at a CAGR of almost 6% during the forecast period. Technavio’s research report traces the growth trajectory of the market and provides a detailed analysis of the prevalent market forces, trends, and drivers which are likely to impact the market in focus. View Free Sample Report
Single-Photon Emission Computed Tomography (SPECT) Market: Segmentation by Product
This report provides a detailed analysis of the market by Product (Standalone SPECT and Hybrid SPECT), Geography (North America, Europe, Asia, and ROW), and Application (Cardiology, Oncology, Neurology, and Others). This research report will provide insights into the current market share of each segment along with growth projections for the next five years. In addition, the report also offers a detailed impact analysis of various trends, drivers, and challenges which are likely to influence market growth during the forecast period. These insights are expected to equip clients with reliable information based upon which they can design a growth strategy for their business and area of operations.
Single-Photon Emission Computed Tomography (SPECT) Market: Vendor Analysis
The market is concentrated. The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions. Bruker Corp., DDD-Diagnostic AS, Digirad Corp., General Electric Co., Koninklijke Philips NV, Mediso Ltd., MiE GmbH, MILabs BV, Siemens Healthineers AG, and Spectrum Dynamics Medical Inc. are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their position in the slow-growing segments.
For more insights into this market: Download a Free Sample Report. Our custom reports provide market insights at the global and regional level along with a pipeline analysis of new product launches. It also provides a peek into the latest R&D along with an impact analysis of government regulations.
The SPECT Market is expected to grow by USD 620.21 million accelerating at a CAGR of over 6% during the forecast period. Technavio’s research report traces the growth trajectory of the market and provides a detailed analysis of the prevalent market forces, trends, and drivers which are likely to impact the market in focus. Download our free sample
Single-Photon Emission Computed Tomography (SPECT) Market: Segmentation by Product
During 2019, the stand alone segment dominated the global Single-Photon Emission Computed Tomography Market in 2019. The market penetration of standalone SPECT systems is increasing globally, owing to the increasing number of cardiovascular and tumor cases. Additionally, low budgetary requirements for the installation of upgraded SPECT units are supporting the revenue growth in the segment. However, market growth in the standalone SPECT segment will be slower than the growth of the market in the hybrid SPECT segment. This report provides an accurate prediction of the contribution of all the segments to the growth of the single-photon emission computed tomography market size.
One of the primary drivers for this market is the rise in the adoption of the SPECT/CT hybrid imaging system. The market has been witnessing the growing adoption of SPECT/CT hybrid imaging technology owing to its advantages such as early diagnosis, accurate disease staging, and effective response to the treatment of chronic conditions such as diabetes.
Also, the increasing demand for SPECT/CT hybrid imaging systems is due to technological advances, decreasing prices, increasing awareness among end-users, and better reimbursement policies. Moreover, vendors are improving their technological capabilities of the SPECT/CT hybrid imaging system. This will further improve the adoption rates worldwide, which, in turn, will propel the growth of the SPECT market during the forecast period.
Single-Photon Emission Computed Tomography (SPECT) Market: Vendor Analysis
The market is concentrated. The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions. Bruker Corp., DDD-Diagnostic AS, Digirad Corp., General Electric Co., Koninklijke Philips NV, Mediso Ltd., MiE GmbH, MILabs BV, Siemens Healthineers AG, and Spectrum Dynamics Medical Inc. are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their position in the slow-growing segments.
Technavio forecasts three scenarios (optimistic, probable, and pessimistic) to evaluate the impact of COVID-19 Download a Free Sample Report. This customized report will help clients keep up with new product launches in direct & indirect COVID-19 related markets. It will also provide insights on upcoming developments along with pipeline analysis of vendor operations and the impact of government regulations.
